Raymond James Financial’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$986K Buy
89,096
+16,951
+23% +$104K ﹤0.01% 4000
2026
Q1
$552K Buy
72,145
+24,781
+52% +$189K ﹤0.01% 4284
2025
Q4
$460K Sell
47,364
-139,630
-75% -$1.19M ﹤0.01% 4320
2025
Q3
$784K Buy
186,994
+179,580
+2,422% +$1.15M ﹤0.01% 3839
2025
Q2
$68.9K Buy
+7,414
New +$64.7K ﹤0.01% 5049

Other funds holding REPL

Raymond James Financial's REPL Position: Q2 2026 in Review

Raymond James Financial increased its Replimune Group (REPL) stake by 23% in Q2 2026, buying an estimated $104K and bringing the position to 89,096 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #4000.

Raymond James Financial first reported a position in REPL in Q2 2025 and has held it in 5 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Raymond James Financial held 89,096 shares of Replimune Group worth $986K as of Q2 2026.
  • Raymond James Financial bought 16,951 Replimune Group shares in Q2 2026, an estimated $104K.
  • Replimune Group made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4000 holding.
  • Raymond James Financial first reported a position in Replimune Group in Q2 2025 and has held it in 5 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.